Nephrotic range proteinuria in c-ANCA-positive crescentic glomerulonephritis with linear immune deposits
- PMID: 20142931
- PMCID: PMC2813536
- DOI: 10.4103/0971-4065.45294
Nephrotic range proteinuria in c-ANCA-positive crescentic glomerulonephritis with linear immune deposits
Abstract
The three broad groups of rapidly progressing glomerulonephritis are anti glomerular basement membrane (anti-GBM) disease, renal vasculitis characterized by antineutrophil cytoplasmic antibody positivity, and a heterogeneous group with granular immune deposits. Anti-GBM disease with cytoplasmic antineutrophilic antibodies (c-ANCA) positivity (type III disease) is not known to present with nephrotic syndrome. We report here a rare presentation of nephrotic syndrome in Type III disease. Larger studies are warranted to determine whether the amount and/or type of immune deposits decide the range of proteinuria. These studies are also required to elucidate the impact of immune complex deposition on renal disease in c-ANCA-positive glomerulonephritis and to outline its pathogenetic mechanism.
Keywords: Anti-GBM disease; nephrotic syndrome; rapidly progressive glomerulonephritis.
Conflict of interest statement
Figures
Similar articles
-
Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria.Ren Fail. 2018 Nov;40(1):554-560. doi: 10.1080/0886022X.2018.1487865. Ren Fail. 2018. PMID: 30278797 Free PMC article.
-
[A clinical and pathological analysis of 41 patients with anti-glomerular basement membrane antibody related diseases].Zhonghua Nei Ke Za Zhi. 2001 May;40(5):316-20. Zhonghua Nei Ke Za Zhi. 2001. PMID: 11798594 Chinese.
-
ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.Am J Kidney Dis. 2000 Oct;36(4):709-18. doi: 10.1053/ajkd.2000.17615. Am J Kidney Dis. 2000. PMID: 11007672
-
Rapidly progressive crescentic glomerulonephritis: Early treatment is a must.Autoimmun Rev. 2014 Jul;13(7):723-9. doi: 10.1016/j.autrev.2014.02.007. Epub 2014 Mar 19. Autoimmun Rev. 2014. PMID: 24657897 Review.
-
Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.Am J Kidney Dis. 2005 Aug;46(2):253-62. doi: 10.1053/j.ajkd.2005.05.003. Am J Kidney Dis. 2005. PMID: 16112043 Review.
Cited by
-
Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria.Ren Fail. 2018 Nov;40(1):554-560. doi: 10.1080/0886022X.2018.1487865. Ren Fail. 2018. PMID: 30278797 Free PMC article.
References
-
- Bosch X, Mirapeix E, Font J, Borrellas X, Rodríguez R, López-Soto A, et al. Prognostic implication of anti-neutrophilic cytoplasmic autoantibodies with myeloperoxidase specifity in anti-glomerular basement membrane disease. Clin Nephrol. 1991;36:107–13. - PubMed
-
- Saxena R, Isaksson B, Bygren P, Wieslander J. A rapid assay for circulating anti-glomerular basement membrane antibodies in Goodpasture syndrome. J Immunol Methods. 1989;118:73–8. - PubMed
-
- Neumann I, Regelez H, Kain R, Birck R, Meisl FT. Glomerular immune deposits are associated with increased proteinuria in patients with ANCA- associated crescentic glomerulonephritis. Nephrol Dial Transplant. 2003;18:524–31. - PubMed
-
- Andrassy K, Waldherr R, Erb A, Ritz E. De novo glomerulonephritis in patients during remission from Wegner's granulomatosis. Clin Nephrol. 1992;38:295–8. - PubMed
-
- Hass M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Am J Kidney Dis. 2000;36:709–18. - PubMed